Avanos Medical (AVNS) EBT (2013 - 2026)

Avanos Medical (AVNS) has 14 years of EBT data on file, last reported at $7.6 million in Q1 2026.

• For the quarter ending Q1 2026, EBT fell 21.65% year-over-year to $7.6 million; the trailing twelve-month figure through Mar 2026 stood at -$68.3 million (up 82.71% YoY), and the FY2025 full-year result was -$66.2 million, up 83.59% from the prior year.
• EBT improved to $7.6 million in Q1 2026, from $1.2 million in the prior quarter.
• In the past five years, EBT ranged from a high of $14.3 million in Q4 2022 to a low of -$420.5 million in Q4 2024.
• A 5-year average of -$25.3 million and a median of $6.2 million in 2024 frame the typical range for EBT.
• Across the five-year window, EBT tumbled 4824.72% in 2024 and surged 546.67% in 2025, its largest moves.
• Tracing AVNS's EBT over 5 years: stood at $14.3 million in 2022, then sank by 37.76% to $8.9 million in 2023, then plunged by 4824.72% to -$420.5 million in 2024, then soared by 100.29% to $1.2 million in 2025, then jumped by 533.33% to $7.6 million in 2026.
• Business Quant data shows AVNS's EBT at $7.6 million in Q1 2026, $1.2 million in Q4 2025, and -$1.2 million in Q3 2025.